Please login to the form below

Not currently logged in
Email:
Password:

ACM Global Central Laboratory appoints Timo Jackle

He joins from Bausch & Lomb

ACM_Timo_JackleTimo Jackle has joined US-based firm ACM Global Central Laboratory as vice president of clinical trials operations.

Jackle moves to the company from Bausch & Lomb, where he served most recently as executive director of global clinical trials operations, overseeing multinational pharmaceutical and medical device studies.

Angela Panzarella, president of ACM, said: “Timo is a highly collaborative leader with extensive experience in clinical trials research, quality assurance, global operations, and business process improvement.

“His strong focus on customer service and lengthy track record in improving business processes will no doubt be an asset to our clients.”

At ACM, Jackle joins the company's executive management team and in his new role he will be responsible for overseeing project management, data management, study support, specimen management, and logistics activities for all of ACM Global's US-based clinical trials.

He will also be tasked with developing and implementing its strategy for operations globally.

2nd May 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Conferences, Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics